Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
ResearchHealthcare, Consumer Staples, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Nucleic Acid Drug CDMO Olipharma Raises Tens of Mns of CNY in Pre-Series A Round
As a new way to treat diseases, gene therapy has higher R&D investment and risk than biochemical drugs. Both pharmaceutical giants and start-ups tend to collaborate with outsourcing service providers, which brings business opportunities to cell and gene therapy contract development and manufacturing organizations (CDMOs).
Yesterday 09:59 PM
Cell Therapy Developer Senlang Bio Raises CNY 200 Million in New Funding Round
Founded in 2016, Hebei Senlang Bio is a clinical-stage biotechnology company dedicated to utilizing cell and gene engineering technologies to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers.
Yesterday 01:00 PM